Current understanding of disseminated intravascular coagulation

被引：106

作者：

Levi, M ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Internal Med, NL-1105 AZ Amsterdam, Netherlands

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 124卷 / 05期

关键词：

D O I：

10.1046/j.1365-2141.2003.04790.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：567 / 576

页数：10

共 80 条

[1] Aortic aneurysm-induced disseminated intravascular coagulation [J].

Aboulafia, DM ;

Aboulafia, ED .

ANNALS OF VASCULAR SURGERY, 1996, 10 (04) :396-405

[2] Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study [J].

Abraham, E ;

Reinhart, K ;

Svoboda, P ;

Seibert, A ;

Olthoff, D ;

Dal Nogare, A ;

Postier, R ;

Hempelmann, G ;

Butler, T ;

Martin, E ;

Zwingelstein, C ;

Percell, S ;

Shu, V ;

Leighton, A ;

Creasey, AA .

CRITICAL CARE MEDICINE, 2001, 29 (11) :2081-2089

[3] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[4] Time course of platelet counts in critically ill patients [J].

Akca, S ;

Haji-Michael, P ;

de Mendonça, A ;

Suter, P ;

Levi, M ;

Vincent, JL .

CRITICAL CARE MEDICINE, 2002, 30 (04) :753-756

[5]

Alving BM, 1998, HEMATOLOGY, P320

[6] Disseminated intravascular coagulation in acute leukemia [J].

Barbui, T ;

Falanga, A .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (06) :593-604

[7] Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study [J].

Baudo, F ;

Caimi, TM ;

de Cataldo, F ;

Ravizza, A ;

Arlati, S ;

Casella, G ;

Carugo, D ;

Palareti, G ;

Legnani, C ;

Ridolfi, L ;

Rossi, R ;

D'Angelo, A ;

Crippa, L ;

Giudici, D ;

Gallioli, G ;

Wolfler, A ;

Calori, G .

INTENSIVE CARE MEDICINE, 1998, 24 (04) :336-342

[8]

BAUER KA, 1987, BLOOD, V70, P343

[9] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[10] Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response [J].

Bick, RL .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (01) :69-88

← 1 2 3 4 5 6 7 8 →